Effect of marine mangrove avicennia marina (Forssk.) vierh against acetic acid-induced ulcerative colitis in experimental mice

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 31, Issue 2, 2012, Pages 179-192

  Victoria Rise, C L ^a   Vinod Prabhu, V ^a   Guruvayoorappan, C ^a  

^a KARUNYA UNIVERSITY   (India)

Author keywords

Antioxidant; Avicennia marina; Flavonoids; Free radicals; Inflammation; Inflammatory bowel disease; Mangrove; Ulcerative colitis

Indexed keywords

4 THIAZOLIDINONE DERIVATIVE; ACETIC ACID; AVICENNIA MARINA EXTRACT; DECANOIC ACID; FENCLONINE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDE; NITRIC OXIDE; PLANT EXTRACT; PYRROLIDINE DERIVATIVE; SALAZOSULFAPYRIDINE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VALERIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVICENNIA MARINA; CONTROLLED STUDY; EPITHELIUM CELL; ERYTHROCYTE; HISTOPATHOLOGY; MALE; MANGROVE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ACETIC ACID; ANIMALS; AVICENNIA; COLITIS, ULCERATIVE; COLON; DISEASE MODELS, ANIMAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDES; MALE; MICE; MICE, INBRED BALB C; PHYTOTHERAPY; PLANT EXTRACTS; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME;

AVICENNIA MARINA; MUS;

EID: 84871278831     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.v31.i2.90     Document Type: Article

References (53)

1. Triantfillidis JK, Nasioulas G, Kosmidis PA. Colorectal cancer and inflammatory bowel diseases: epidemiology, risk factors, mechanism of car cinogenesis and prevention strategies. Anticancer Res. 2009;29:2727-2737.
2. Green L, Elliott L, Beaudoin C, Bernstein C.N. Clues to the etiology of inflammatory bowel disease. Am J Epidemiol. 2006;164:627-628.
3. Bernstein C.N Blanchard J.F. Epidemiology of inflammatory bowel disease. In: Cohen RD, editor. Inflammatory bowel disease: diagnosis and therapeutics. Totowa, NJ: Humana Press;2003. p. 17-32.
4. Thia KT, Loftus EV Jr, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008;103:3167-3182.
5. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504-1517.
6. Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol. 2012;27:1266-1280.
7. Medhi B, Prakash A, Avti PK, Saikia UN, Pandhi P, Khanduja KL. Effect of Manuka honey and sulfasalazine in combination to promote antioxidant defense system in experimentally induced ulcerative colitis model in rats. Indian J Exp Biol. 2008;46:583-590.
8. Danese S, Mantovani A. Inflammatory bowel disease and intestinal cancer: a paradigm of the YinYang interplay between inflammation and cancer. Oncogene. 2010;29:3313-3323.
9. Seril DN, Liao J, Yang GY, Yang CS. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis. 2003;24:353-362.
10. Chu FF, Esworthy RS, Chu PG, Longmate JA, Huycke MM, Wilczynski S, Doroshow JH. Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 Genes. Cancer Res. 2004;64:962- 968.
11. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol. 2004;287:G7-G17.
12. Xu L. Dr. Dong Demao's experience in treating chronic ulcerative colitis. J Tradit Chin Med. 2004;24:243-246.
13. Nielsen OH, Bukhave K, Elmgreen J, Ahnfelt RI. Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neurtrophils by sulfasalazine and 5-aminosalicylic acid. Dig Dis Sci. 1987;32:577-582.
14. Lauritsen K, Hausen J, Bytzer P, Bukhave K, Rask Madsen J. Effects of sulfazalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls. Gut. 1984;25:1271-1278.
15. Dick AP, Grayson MJ, Carpenter RG, Petrie A. Controlled trial of sulfasalazine in the treatment of ulcerative colitis. Gut. 1964;5:437-442.
16. Anthonisen P, Barany F, Folkenborg O, Holtz A, Jarnum S, Kristensen M, Riis P, Walan A, Worning H. The clinical effect of salazosulphaphyridine (salazopyrin) in Crohn's disease. A controlled double-blind study. Scand J Gastroenterol. 1974;9:549-554.
17. Velciov S, Gluhovschi G, Sporea I, Trandafirescu V, Petrica L, Bozdog G, Gluhovschi C, Bob F, Gǎdǎlean F, Buzaş R, Bobu M, Voicu L. Asymptomatic urinary anomalies, hematuria and proteinuria, in patients with inflammatory bowel disease. Preliminary study. Rom J Intern Med. 2011;49:113-120.
18. Thippeswamy BS, Mahendran S, Biradar MI, Raj P, Srivastava K, Badami S, Veerapur VP. Protective effect of embelin against acetic acid induced ulcerative colitis in rats. Eur J Pharmacol. 2011;654:100-105.
19. Prabhu VV, Guruvayoorappan C. Nitric oxide: pros and cons in tumor progression. Immunopharmacol Immunotoxicol. 2010;32:387-392.
20. Prabhu VV, Guruvayoorappan C. Phytochemical screening of methanolic extract of mangrove Avicennia marina (Forssk.) Vierh. Der Pharmacia Sinica. 2012;3:64-70.
21. Bandaranayake WM. Bioactivities, bioactive compounds and chemical constituents of mangrove plants. Wetlands Ecol Manage 2002;10:421-452.
22. Zhang Y, Lu Y, Mao L, Proksch P, Lin WH. Tagalsins I and J, two novel tetraterpenoids from the mangrove plant, Ceriops tagal. Org Lett. 2005;7:3037-3040.
23. Pakhathirathien C, Karalai C, Ponglimanot C, Subhadhirasakul S, Chantrapromma, K. Dammarane triterpenes from the hypocotyls and fruits of Ceriops tagal. J Nat Prod. 2005;68:1787-1789.
24. Jia R, Guo YW, Hou HX. Studies on the chemical constituents from leaves of Avicennia marina. Chin J Nat Med. 2004;2:16-19.
25. Sharaf M, El-Ansari MA, Saleh NA. New flavonoids from Avicennia marina. Fitoterapia. 2000;71:274-277.
26. Ravikumar S, Inbaneson SJ, Suganthi P, Venkatesan M, Ramu A. Mangrove plants as a source of lead compounds for the development of new antiplasmodial drugs from South East coast of India. Parasitol Res2011;108:1405-1410.
27. Afzal M, Mehdi FS, Fida MA, Ahmad H, M.RInamullah, Alam J, Jan G, Islam M, Ul Amin N, Majid A, Fiaz M, Shah AH Efficacy of Avicennia marina (Forsk.) Vierh. leaves extracts against some atmospheric fungi. Afr J Biotechnol. 2011;10:10790-10794.
28. Mokkhasmit M, Swatdimongkol K, Satrawaha P. Study on toxicity of Thai medicinal plants. Bull Dept Med Sci.1971;12:36-65.
29. Cole SP. Rapid chemosensitivity testing of human lung tumor cells using the MTT assay. Cancer Chemother Pharmacol. 1986;17:259-263.
30. Kuttan R, Bhanumathy P, Nirmala K, George MC. Possible anti-cancer activity of turmeric. Nutr Cancer. 1985;29:197-202.
31. Jagtap AG, Shirke SS, Phadke AS. Effect of polyherbal formulation on experimental models of in?ammatory bowel diseases. J Ethnopharmacol. 2004;90:195-204.
32. Dodge JT, Mitchell C, Hanhan DJ. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys. 1963;100:119-130.
33. Quist EE. Regulation of the shape of unsealed erythrocyte membranes by Mg-ATP and Ca2+. Arch Biochem Biophys. 1980;203:123-133.
34. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin-phenol reagents. J Biol Chem. 1951;193:265-275.
35. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-358.
36. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973;9;179:588-590.
37. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem. 1982;126:131-138.
38. Kakkar PS, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Ind J Biochem Biophys. 1984;21:130-132.
39. Beutler E, Kelly BM. The effect of sodium nitrite on red cell GSH. Experientia. 1963;15;19:96-97.
40. Sunkara S, Swanson G, Forsyth CB, Keshavarzian A. Chronic inflammation and malignancy in ulcerative colitis. Ulcers. 2011;(2011):1-8.
41. Kulaylat MN, Dayton MT. Ulcerative colitis and cancer. J Surg Oncol. 2010;101;706-712.
42. Kimura W, Makuuchi M, Kuroda A. Characteristics and treatment of mucin-producing tumor of the pancreas. Hepatogastroenterology. 1998;45:2001-2008
43. Rachmilewitz D, Simon PL, Schwartz LW, Gris-wold DE, Fondacaro JD, Wasserman MA. Inflammatory mediators of experimental colitis in rats. Gastroenterology. 1989;97:326-337.
44. Alzoghaibi MA, Al Mofleh IA, Al-Jebreen AM. Lipid peroxides in patients with inflammatory bowel disease. Saudi J Gastroenterol. 2007;13:187-190.
45. Pryor WA, Stanley JP. Letter: A suggested mechanism for the production of malonaldehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation. J Org Chem. 1975;40:3615-3617.
46. Chavan S, Sava L, Saxena V, Pillai S, Sontakke A, Ingole D. Reduced glutathione: importance of specimen collection. Indian J Clin Biochem. 2005;20;150-152.
47. Kruidenier L, Kuiper I, Van Duijn W, Mieremet Ooms MA, van Hogezand RA, Lamers CB, Verspaget HW. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol. 2003;201:17-27.
48. García-González A, Lotz M, Ochoa JL. Antiinflammatory activity of superoxide dismutase obtained from Debaryomyces hansenii on type II collagen induced arthritis in rats. Rev Invest Clin. 2009;61:212-220.
49. Drew JE, Arthur JR, Farquharson AJ, Russell WR, Morrice PC, Duthie GG. Salicylic acid modulates oxidative stress and glutathione peroxidase activity in the rat colon. Biochem. Pharmacol. 2005;70:888-893.
50. Wong VK, Yu L, Cho CH. Protective effect of polysaccharides from Angelica sinensis on ulcerative colitis in rats. Inflammopharmacology. 2008;16:162-167.
51. Kolios G, Valatas V, Ward SG. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology. 2004;113:427-437.
52. Gillberg L, Varsanyi M, Sjöström M, Lördal M, Lindholm J, Hellström PM. Nitric oxide pathwayrelated gene alterations in inflammatory bowel disease. Scand J Gastroenterol. 2012;47:1283- 1297.
53. Feng Y, Li XM, Duan XJ, Wang BG. A new acylated iridoid glucoside from Avicennia marina. Chin Chem Lett. 2006;17:1201-1204.